AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
5.45
-0.17 (-3.02%)
At close: Nov 20, 2026, 4:00 PM EST
5.44
-0.01 (-0.18%)
After-hours: Nov 20, 2026, 5:00 PM EST
AgomAb Therapeutics NV Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +542.20% | Nov 16, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $28 | Buy | Reiterates | $28 | +413.76% | Nov 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 | Buy | Maintains | $60 | +1,000.92% | Oct 14, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $36 | Buy | Reiterates | $36 | +560.55% | Oct 2, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 → $17 | Buy | Initiates | $13 → $17 | +211.93% | Aug 19, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $34 | Buy | Initiates | $34 | +523.85% | Jul 23, 2026 |